Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Am J Med. 2013 Mar;126(3):256-63. doi: 10.1016/j.amjmed.2012.06.037. Epub 2013 Jan 18.
Electrolyte disorders have been studied mainly in hospitalized patients, whereas data in the general population are limited. The aim of this study was to determine the prevalence and risk factors of common electrolyte disorders in older subjects recruited from the general population.
A total of 5179 subjects aged 55 years or more were included from the population-based Rotterdam Study. We focused on hyponatremia, hypernatremia, hypokalemia, hyperkalemia, and hypomagnesemia. Multivariable logistic regression was used to study potential associations with renal function, comorbidity, and medication. The adjusted mortality also was determined for each electrolyte disorder.
A total of 776 subjects (15.0%) had at least 1 electrolyte disorder, with hyponatremia (7.7%) and hypernatremia (3.4%) being most common. Diabetes mellitus was identified as an independent risk factor for hyponatremia and hypomagnesemia, whereas hypertension was associated with hypokalemia. Diuretics were independently associated with several electrolyte disorders: thiazide diuretics (hyponatremia, hypokalemia, hypomagnesemia), loop diuretics (hypernatremia, hypokalemia), and potassium-sparing diuretics (hyponatremia). The use of benzodiazepines also was associated with hyponatremia. Hyponatremic subjects who used both thiazides and benzodiazepines had a 3 mmol/L lower serum sodium concentration than subjects using 1 or none of these drugs (P < .001). Hyponatremia and hypomagnesemia were independently associated with an increased mortality risk.
Electrolyte disorders are common among older community subjects and mainly associated with diabetes mellitus and diuretics. Subjects who used both thiazides and benzodiazepines had a more severe degree of hyponatremia. Because even mild electrolyte disorders were associated with mortality, monitoring of electrolytes and discontinuation of offending drugs may improve outcomes.
电解质紊乱主要在住院患者中进行研究,而在普通人群中的数据有限。本研究的目的是确定从普通人群中招募的老年受试者中常见电解质紊乱的患病率和危险因素。
共纳入来自人群为基础的鹿特丹研究的 5179 名 55 岁或以上的受试者。我们重点研究低钠血症、高钠血症、低钾血症、高钾血症和低镁血症。多变量逻辑回归用于研究与肾功能、合并症和药物治疗的潜在关联。还确定了每种电解质紊乱的调整死亡率。
共有 776 名(15.0%)受试者至少存在 1 种电解质紊乱,其中低钠血症(7.7%)和高钠血症(3.4%)最常见。糖尿病被确定为低钠血症和低镁血症的独立危险因素,而高血压与低钾血症有关。利尿剂与几种电解质紊乱独立相关:噻嗪类利尿剂(低钠血症、低钾血症、低镁血症)、袢利尿剂(高钠血症、低钾血症)和保钾利尿剂(低钠血症)。苯二氮䓬类药物的使用也与低钠血症有关。与使用 1 种或 1 种以上这些药物的受试者相比,同时使用噻嗪类和苯二氮䓬类药物的低钠血症受试者的血清钠浓度低 3mmol/L(P <.001)。低钠血症和低镁血症与死亡率增加独立相关。
电解质紊乱在老年社区受试者中很常见,主要与糖尿病和利尿剂有关。同时使用噻嗪类和苯二氮䓬类药物的受试者低钠血症程度更严重。由于即使是轻度电解质紊乱也与死亡率相关,因此监测电解质和停用致病药物可能会改善预后。